Frequency of hemorrhagic complications on abdominal CT in patients with warfarin therapy

Sunyoung Lee1, Dongil Choi1, Woo Kyoung Jeong1

  • 1Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Clinical Imaging
|May 3, 2016
PubMed

Insights

Hemorrhagic complications occurred in 11.5% of patients on warfarin therapy undergoing abdominal CT scans. Higher anticoagulation intensity (INR) was linked to increased bleeding risk.

Area of Science:

  • Radiology
  • Internal Medicine
  • Pharmacology

Background:

  • Warfarin is a common anticoagulant.
  • Abdominal CT scans are frequently used in clinical practice.
  • Hemorrhagic complications are a known risk of anticoagulation therapy.

Purpose of the Study:

  • To determine the incidence of hemorrhagic complications on abdominal CT in patients receiving warfarin.
  • To assess the relationship between anticoagulation intensity and bleeding risk.

Main Methods:

  • A retrospective study of 646 patients on warfarin therapy.
  • Inclusion criteria: International Normalized Ratio (INR) > 3.0 and abdominal CT within one month of INR measurement.
  • Analysis of abdominal CT scans for hemorrhagic complications.

Main Results:

  • Hemorrhagic complications were identified in 74 patients (11.5%).
  • A statistically significant correlation was found between the frequency of hemorrhagic complications and anticoagulation intensity (P<.001).

Conclusions:

  • Hemorrhagic complications are not uncommon in patients on warfarin therapy undergoing abdominal CT.
  • Higher INR values are associated with a greater likelihood of bleeding complications.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
459
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
364
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K